July 02, 2025 FDA Approves Ready-to-Infuse Vancomycin Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis. Conexiant
June 30, 2025 AACR 2025: Use of ctDNA-Based Liquid Biopsy Assay in Resectable Colorectal Cancer The ASCO Post
June 25, 2025 AACR 2025: Trends in Breast Cancer Incidence for Women Between the Ages of 20 and 49 The ASCO Post
June 16, 2025 AACR 2025: Trends in Breast Cancer Incidence for Women Between the Ages of 20 and 49 The ASCO Post
June 30, 2025 Adjuvant Use of Atezolizumab Plus Chemotherapy in DNA Mismatch Repair–Deficient Colon Cancer The ASCO Post
July 01, 2025 New Study Shows Tiny Cuts Could Improve Brain Surgery: A Simpler, Safer Way to Treat Brain Tumors Baptist Health South Florida
June 30, 2025 Adjuvant Use of Atezolizumab Plus Chemotherapy in DNA Mismatch Repair–Deficient Colon Cancer The ASCO Post
June 17, 2025 Baptist Health Announces 42nd Annual Echocardiography and Structural Heart Symposium Baptist Health South Florida
March 21, 2023 There is an “I” in Team: Maximizing Your Contributions to Promote Team Success Barnes-Jewish
June 10, 2025 Why Most Instrument Startups Fail – and What to Do Differently The Analytical Scientist
May 01, 2025 Eye On OOSS: The Innovation-Efficiency Paradox in Ophthalmic ASCs Ophthalmology Management